These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34663705)

  • 41. Self-reported levels of education and disability progression in multiple sclerosis.
    D'hooghe MB; Haentjens P; Van Remoortel A; De Keyser J; Nagels G
    Acta Neurol Scand; 2016 Dec; 134(6):414-419. PubMed ID: 27761897
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The relationship between dysphagia, respiratory functions and anthropometry in patients with multiple sclerosis.
    Eren F; Ozkan B; Demir A
    Mult Scler Relat Disord; 2021 Oct; 55():103192. PubMed ID: 34371272
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retinal nerve fiber layer thickness and neurologic disability in relapsing-remitting multiple sclerosis.
    Behbehani R; Al-Hassan AA; Al-Khars A; Sriraman D; Alroughani R
    J Neurol Sci; 2015 Dec; 359(1-2):305-8. PubMed ID: 26671132
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Longitudinal disability curves for predicting the course of relapsing-remitting multiple sclerosis.
    Achiron A; Barak Y; Rotstein Z
    Mult Scler; 2003 Oct; 9(5):486-91. PubMed ID: 14582775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relapses add to permanent disability in relapsing multiple sclerosis patients.
    Koch-Henriksen N; Sørensen PS; Magyari M
    Mult Scler Relat Disord; 2021 Aug; 53():103029. PubMed ID: 34116481
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran.
    Pakdaman H; Amini Harandi A; Gharagozli K; Abbasi M; Tabassi A; Ashrafi F; Ghaffarpor M; Sharifi S; Delavar Kasmae H; Assarzadegan F; Arabahmadi M; Behnam B
    Int J Neurosci; 2017 Jun; 127(6):501-507. PubMed ID: 27279451
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anodal tDCS of the swallowing motor cortex for treatment of dysphagia in multiple sclerosis: a pilot open-label study.
    Cosentino G; Gargano R; Bonura G; Realmuto S; Tocco E; Ragonese P; Gangitano M; Alfonsi E; Fierro B; Brighina F; Salemi G
    Neurol Sci; 2018 Aug; 39(8):1471-1473. PubMed ID: 29756180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic inertia in relapsing-remitting multiple sclerosis.
    Rodrigues R; Rocha R; Bonifácio G; Ferro D; Sabença F; Gonçalves AI; Correia F; Pinheiro J; Loureiro JL; Guerreiro RP; Vale J; Sá MJ; Costa A
    Mult Scler Relat Disord; 2021 Oct; 55():103176. PubMed ID: 34343868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association between clinical evaluation and self perception of deglutition with motor disability scale in patients with multiple sclerosis.
    Piloti DTW; Ruiz VCD; Ribeiro MC; Almeida ST
    Codas; 2022; 34(2):e20210026. PubMed ID: 35019079
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of cognitive impairment among Hungarian patients with relapsing-remitting multiple sclerosis and clinically isolated syndrome.
    Sandi D; Biernacki T; Szekeres D; Füvesi J; Kincses ZT; Rózsa C; Mátyás K; Kása K; Matolcsi J; Zboznovits D; Burány Z; Langane É; Vécsei L; Bencsik K
    Mult Scler Relat Disord; 2017 Oct; 17():57-62. PubMed ID: 29055476
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Myotonometric comparison of sternocleidomastoideus and masseter muscles in multiple sclerosis patients with swallowing problem and healthy individuals.
    Maden T; Usgu G; Tuncer A
    Mult Scler Relat Disord; 2022 Jan; 57():103387. PubMed ID: 35158437
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of anxiety symptoms and correlates of anxiety in people with progressive and relapsing-remitting multiple sclerosis.
    Knowles LM; Tingey JL; Newman AK; von Geldern G; Alschuler KN
    Mult Scler Relat Disord; 2022 Jul; 63():103918. PubMed ID: 35700673
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Magnetization transfer ratio histogram analysis of gray matter in relapsing-remitting multiple sclerosis.
    Ge Y; Grossman RI; Udupa JK; Babb JS; Kolson DL; McGowan JC
    AJNR Am J Neuroradiol; 2001 Mar; 22(3):470-5. PubMed ID: 11237968
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis.
    Amato MP; Fonderico M; Portaccio E; Pastò L; Razzolini L; Prestipino E; Bellinvia A; Tudisco L; Fratangelo R; Comi G; Patti F; De Luca G; Brescia Morra V; Cocco E; Pozzilli C; Sola P; Bergamaschi R; Salemi G; Inglese M; Millefiorini E; Galgani S; Zaffaroni M; Ghezzi A; Salvetti M; Lus G; Florio C; Totaro R; Granella F; Vianello M; Gatto M; Di Battista G; Aguglia U; Logullo FO; Simone M; Lucisano G; Iaffaldano P; Trojano M
    Brain; 2020 Oct; 143(10):3013-3024. PubMed ID: 32935843
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Disability outcome measures in therapeutic trials of relapsing-remitting multiple sclerosis: effects of heterogeneity of disease course in placebo cohorts.
    Liu C; Blumhardt LD
    J Neurol Neurosurg Psychiatry; 2000 Apr; 68(4):450-7. PubMed ID: 10727480
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis.
    Hofstetter L; Naegelin Y; Filli L; Kuster P; Traud S; Smieskova R; Mueller-Lenke N; Kappos L; Gass A; Sprenger T; Penner IK; Nichols TE; Vrenken H; Barkhof F; Polman C; Radue EW; Borgwardt SJ; Bendfeldt K
    Mult Scler; 2014 Feb; 20(2):202-13. PubMed ID: 23804554
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dysphagia in multiple sclerosis - prevalence and prognostic factors.
    Calcagno P; Ruoppolo G; Grasso MG; De Vincentiis M; Paolucci S
    Acta Neurol Scand; 2002 Jan; 105(1):40-3. PubMed ID: 11903107
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis.
    Gava G; Bartolomei I; Costantino A; Berra M; Venturoli S; Salvi F; Meriggiola MC
    Fertil Steril; 2014 Jul; 102(1):116-22. PubMed ID: 24794311
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Parity and disability progression in relapsing-remitting multiple sclerosis.
    Achiron A; Ben-David A; Gurevich M; Magalashvili D; Menascu S; Dolev M; Stern Y; Ziv-Baran T;
    J Neurol; 2020 Dec; 267(12):3753-3762. PubMed ID: 32725314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.